321Foundation
  • About
    • A Letter from Our President
    • What We Believe
    • History
    • Board of Directors & Executive Team
    • Teaching Team
    • Contact
  • Education
    • Overview
    • Learning Program Boston
    • Educational Consulting
    • Education Resources
  • Cognition
    • Overview
    • Research Monitoring
    • Ignition Program™
    • Statement on the Use of Human Biological Material
    • Cognition Resources
  • Advocacy
    • Overview
    • Advocacy Resources
  • News
  • Support Us
  • Donate
  • Search
  • Menu Menu

First clinical trial for vaccine targeting Alzheimer’s in people with Down’s syndrome

Health, In the Media

by Nicholas Jackson | drugtargetreview.com

Plans for the world’s first clinical trial for a vaccine targeting Alzheimer’s disease-like characteristics in those with Down’s syndrome have been announced. The study will test AC Immune’s vaccine ACI-24 and is being conducted in collaboration with the University of California, San Diego (UC San Diego) Down’s Syndrome Research and Treatment Center. Funding is provided by a significant grant from the US National Institutes of Health (NIH) and an additional grant from the LuMind Research Down’s Syndrome Foundation. This is the first public/private collaboration for a clinical trial in the field of Down’s syndrome.

http://www.drugtargetreview.com/8541/content-type/industry-news/vaccine-targeting-alzheimers-in-people-with-down-syndrome/#.Vo6bUU-ng2Y.facebook

January 7, 2016/0 Comments/by Other
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail
https://321foundation.org/wp-content/uploads/2016/03/gl-1-logo.png 95 500 Other https://321foundation.org/wp-content/uploads/2020/05/3-21_Foundation_Logo.png Other2016-01-07 00:11:102016-03-06 18:41:35First clinical trial for vaccine targeting Alzheimer’s in people with Down’s syndrome
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

3-21 Foundation

Categories

  • Advocacy
  • Cognition
  • Education
  • Featured
  • Health
  • In the Media
  • Our Blog

Archives

  • June 2022
  • February 2022
  • September 2020
  • August 2020
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • March 2017
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014

Copyright 2023 © 3-21 Foundation, Inc. All rights reserved.

  • Facebook

Site designed and managed by Body1

Support Our Education and Cognition Efforts with a GiftSpecial Ed Testing Accommodations Backfire
Scroll to top